Literature DB >> 7631357

Ischemic delayed neuronal death. A mitochondrial hypothesis.

K Abe1, M Aoki, J Kawagoe, T Yoshida, A Hattori, K Kogure, Y Itoyama.   

Abstract

BACKGROUND: A brief period of global brain ischemia causes cell death in hippocampal CA1 pyramidal neurons days after reperfusion in rodents and humans. Other neurons are much less vulnerable. This phenomenon is commonly referred to as delayed neuronal death, but the cause has not been fully understood although many mechanisms have been proposed. SUMMARY OF REVIEW: Hippocampal CA1 neuronal death usually occurs 3 to 4 days after an initial ischemic insult. Such a delay is essential for the mechanism of this type of cell death. Previous hypotheses have not well explained the reason for the delay and the exact mechanism of the cell death, but a disturbance of mitochondrial gene expression could be a possibility. Reductions of mitochondrial RNA level and the activity of a mitochondrial protein, encoded partly by mitochondrial DNA, occurred exclusively in CA1 neurons at the early stage of reperfusion and were aggravated over time. In contrast, the activity of a nuclear DNA-encoded mitochondrial enzyme and the level of mitochondrial DNA remained intact in CA1 cells until death. Immunohistochemical staining for cytoplasmic dynein and kinesin, which are involved in the shuttle movement of mitochondria between cell body and the periphery, also showed early and progressive decreases after ischemia, and the decreases were found exclusively in the vulnerable CA1 subfield.
CONCLUSIONS: A disturbance of mitochondrial DNA expression may be caused by dysfunction of the mitochondrial shuttle system and could cause progressive failure of energy production of CA1 neurons that eventually results in cell death. Thus, the mitochondrial hypothesis could provide a new and exciting potential for elucidating the mechanism of the delayed neuronal death of hippocampal CA1 neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631357     DOI: 10.1161/01.str.26.8.1478

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  63 in total

Review 1.  Pharmacological advance in the treatment of acute brain injury.

Authors:  R C Tasker
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

Review 2.  Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia.

Authors:  Miguel A Pérez-Pinzón
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 3.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

Review 4.  Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis).

Authors:  Zoltán Szolnoki
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

5.  Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions.

Authors:  Ruimin Wang; Yan Dong; Yujiao Lu; Wenli Zhang; Darrell W Brann; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2018-06-27       Impact factor: 5.590

6.  Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation.

Authors:  Taku Sugawara; Nobuo Noshita; Anders Lewén; Yvan Gasche; Michel Ferrand-Drake; Miki Fujimura; Yuiko Morita-Fujimura; Pak H Chan
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

7.  Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline.

Authors:  Stefanie Geisler; Antje Willuweit; Michael Schroeter; Karl Zilles; Kurt Hamacher; Norbert Galldiks; Nadim J Shah; Heinz H Coenen; Karl-Josef Langen
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

8.  A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Ferenc Somogyvari
Journal:  Neuromolecular Med       Date:  2007-10-13       Impact factor: 3.843

9.  Expression of phosphatidylinositol (4,5) bisphosphate-specific pleckstrin homology domains alters direction but not the level of axonal transport of mitochondria.

Authors:  Kurt J De Vos; Julia Sable; Kyle E Miller; Michael P Sheetz
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

10.  Intranasal Delivery of a Caspase-1 Inhibitor in the Treatment of Global Cerebral Ischemia.

Authors:  Ningjun Zhao; Xiaoying Zhuo; Yujiao Lu; Yan Dong; Mohammad Ejaz Ahmed; Donovan Tucker; Erin L Scott; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.